St Jude's faster renal denervation device gets EU nod
This article was originally published in Clinica
Executive Summary
St Jude Medical has potentially gained the edge over rival Medtronic in the competitive renal denervation market by CE marking its next-generation EnligHTN device. The device, indicated for the treatment of drug-resistant, uncontrolled hypertension, allows faster treatment, cutting ablation time to four minutes, versus 24 minutes with the first-gen product.